Figure 6.
LC/NK cultures supplemented with allogeneic CD4+ T cells, IL-2, or IL-12 are able to activate NK cells. Size (forward scatter [FSC]), granularity (side scatter [SSC]), and surface expression of the CD56 and CD16 epitopes were quantified by flow cytometry. FSC and SSC were measured on purified NK cells stimulated for 7 days by Langerhans cells (LC) at an NK-cell-DC ratio of 10:1. Cultures were supplemented with irradiated allogeneic CD4+ T cells at an NK/CD4+ T-cell ratio of 1:1 (LC + CD4), 80 IU/mL rIL-2 (LC + IL-2), 500 pg/mL IL-12 (LC + IL-12), or nothing (LC). CD56 and CD16 expression was quantified on gated CD3- lymphocytes, which lacked autofluorescence in channel FL-3 and were located in the FSC/SSC lymphocyte gate (dotted line). Percentages indicate NK-cell blasts, CD16-CD56bright, CD16+CD56bright, and CD16+CD56dim cells. LCs maintained NK-cell viability very well (bottom left panel) despite the absence of activation and blast transformation without supplements. Note that most of the peripheral blood NK cells are CD56dim but not CD56- directly after isolation from PBMCs or after coculture with LCs. The data are representative of 3 independent experiments.